Rapid response to autoimmune hepatitis treatment linked to better outcomes

Patients with autoimmune hepatitis who had a rapid response after treatment were the most likely to achieve normalization of transaminase levels in the following year and had a lower risk for liver-related death or transplantation, according to results of a retrospective study.“Autoimmune hepatitis (AIH) is a rare, chronic liver disease that is characterized by elevated serum transaminases and immunoglobulin G (IgG), inflammatory liver histology and presence of circulating auto antibodies,” Simon Pape, PhD student from the Radboud University Medical in the Netherlands, andRead More